Published in J Radiat Res on December 09, 2015
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol (2002) 4.56
Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys (1993) 1.60
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology (2015) 1.59
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol (2013) 1.54
The role of radiation therapy in the management of primary central nervous system lymphoma. Leuk Lymphoma (2014) 1.48
Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. J Neurooncol (2008) 1.36
Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol (2011) 1.25
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol (2015) 1.17
Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma. Neurology (2013) 1.05
Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study. Int J Radiat Oncol Biol Phys (2008) 1.01
Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases. Cancer (1975) 1.00
Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate. Int J Radiat Oncol Biol Phys (2001) 0.98
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study. J Neurooncol (2008) 0.97
Survival among patients with primary central nervous system lymphoma, 1973-2004. J Neurooncol (2010) 0.96
Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation. Cancer (2003) 0.92
Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s. Int J Radiat Oncol Biol Phys (2005) 0.90
Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer (1990) 0.85
Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma. Jpn J Clin Oncol (2003) 0.82
Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study. J Neurooncol (1999) 0.82
Whither whole brain radiotherapy for primary CNS lymphoma? Neuro Oncol (2014) 0.81
Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated from 1985 to 2009. Clin Oncol (R Coll Radiol) (2014) 0.81
Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. Int J Clin Oncol (2013) 0.80
Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis. Br J Haematol (2010) 0.80
Is there a role for radiotherapy in the primary management of primary central nervous system lymphoma? A single-centre case series. Clin Oncol (R Coll Radiol) (2013) 0.79
Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience. Jpn J Radiol (2016) 0.77
Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control. Int J Clin Oncol (2016) 0.75